Inflammatory Demyelinating Diseases | List of Frontiers open access articles

Review

Published on 08 May 2017

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases

in Multiple Sclerosis and Neuroimmunology

Patrick Peschl
Monika Bradl
Romana Höftberger
Thomas Berger
Markus Reindl

Frontiers in Immunology

doi 10.3389/fimmu.2017.00529

32,919 views
231 citations

Review

Published on 20 Aug 2020

Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases

in Multiple Sclerosis and Neuroimmunology

Zhou Ran
Luo Yue-Bei
Zeng Qiu-Ming
Yang Huan

Frontiers in Immunology

doi 10.3389/fimmu.2020.01884

18,145 views
60 citations

Review

Published on 27 Oct 2022

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases

in Autoimmune and Autoinflammatory Disorders

Li Jiao
Shougang Guo

Frontiers in Immunology

doi 10.3389/fimmu.2022.966766

7,994 views
14 citations

Original Research

Published on 17 Mar 2021

Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg

in Neurogenomics

Soniza Vieira Alves-Leon
Cristina dos Santos Ferreira
Alice Laschuk Herlinger
Fabricia Lima Fontes-Dantas
Fernanda Cristina Rueda-Lopes
Ronaldo da Silva Francisco
João Paulo da Costa Gonçalves
Amanda Dutra de Araújo
Cláudia Cecília da Silva Rêgo
Luiza Mendonça Higa

Frontiers in Genetics

doi 10.3389/fgene.2021.639364

6,815 views
12 citations

Mini Review

Published on 07 May 2025

The potential of repurposing clemastine to promote remyelination

in Cellular Neuropathology

Reiji Yamazaki
Nobuhiko Ohno

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2025.1582902

6,562 views
4 citations

Review

Published on 03 Nov 2020

Rodent Models of Optic Neuritis

in Neuro-Ophthalmology

Yael Redler
Michael Levy

Frontiers in Neurology

doi 10.3389/fneur.2020.580951

9,068 views
19 citations

Original Research

Published on 04 Dec 2019

Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously

in Multiple Sclerosis and Neuroimmunology

Yijun Ren
Xiqian Chen
Qiang He
Renchun Wang
Wei Lu

Frontiers in Neurology

doi 10.3389/fneur.2019.01271

6,382 views
50 citations

Review

Published on 16 May 2023

Central nervous system demyelinating diseases: glial cells at the hub of pathology

in Multiple Sclerosis and Neuroimmunology

Vinicius Gabriel Coutinho Costa
Sheila Espírito-Santo Araújo
Soniza Vieira Alves-Leon
Flávia Carvalho Alcantara Gomes

Frontiers in Immunology

doi 10.3389/fimmu.2023.1135540

17,151 views
55 citations

Review

Published on 18 Nov 2021

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease

in Multiple Sclerosis and Neuroimmunology

Rosa Cortese
Antonio Giorgio
Gianmarco Severa
Nicola De Stefano

Frontiers in Neurology

doi 10.3389/fneur.2021.679881

19,756 views
21 citations

Brief Research Report

Published on 26 Nov 2019

Dimethylsulfoxide Inhibits Oligodendrocyte Fate Choice of Adult Neural Stem and Progenitor Cells

in Neurogenesis

Anna O’Sullivan
Simona Lange
Peter Rotheneichner
Lara Bieler
Ludwig Aigner
Francisco J. Rivera
Sebastien Couillard-Despres

Frontiers in Neuroscience

doi 10.3389/fnins.2019.01242

7,456 views
8 citations

Original Research

Published on 14 Jan 2022

Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease

in Multiple Sclerosis and Neuroimmunology

Ju Liu
Xiaoyan Yang
Jiali Pan
Zhihua Wei
Peidong Liu
Min Chen
Hongbo Liu

Frontiers in Neurology

doi 10.3389/fneur.2021.807646

8,600 views
6 citations

Original Research

Published on 29 May 2020

Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

in Multiple Sclerosis and Neuroimmunology

Chen Chen
Yunting Wu
Miaochang Li
Chunping Cui
Yipeng Zhao
Xiaobo Sun
Yuge Wang
Chunxin Liu
Haotian Wu
Xiaonan Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2020.01064

6,624 views
19 citations

Brief Research Report

Published on 22 Jul 2021

High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica

in Multiple Sclerosis and Neuroimmunology

Qi Zhang
Shanshan Pei
Zheyi Zhou
Zhanhang Wang
Yu Peng
Jinyu Chen
Honghao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2021.705536

5,699 views
11 citations

Original Research

Published on 11 Jul 2022

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD

in Multiple Sclerosis and Neuroimmunology

Liuyu Lin
Yuqing Wu
Hailun Hang
Jie Lu
Yuanliang Ding

Frontiers in Immunology

doi 10.3389/fimmu.2022.853891

7,358 views
23 citations

Original Research

Published on 02 Jul 2024

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

in Multiple Sclerosis and Neuroimmunology

Sara Samadzadeh
Rafl Adnan
Paulina Berglova
Mahdi Barzegar
Birgit Debrabant
Stine Gundtoft Roikjaer
Michael Levy
Axel Petzold
Jacqueline Palace
Eoin P. Flanagan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380025

10,849 views
1 citation

Original Research

Published on 26 Aug 2021

Analysis of Predictive Risk Factors in Aquaporin-4-IgG Positive Highly Active Neuromyelitis Optica Spectrum Disorders

in Multiple Sclerosis and Neuroimmunology

Yanfei Li
Jinwei Zhang
Yongyan Zhou
Haojie Xie
Ranran Duan
Lijun Jing
Yaobing Yao
Junfang Teng
Yanjie Jia

Frontiers in Neurology

doi 10.3389/fneur.2021.731835

4,194 views
7 citations

Articles

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases

Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases

Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg

The potential of repurposing clemastine to promote remyelination

Rodent Models of Optic Neuritis

Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously

Central nervous system demyelinating diseases: glial cells at the hub of pathology

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease

Dimethylsulfoxide Inhibits Oligodendrocyte Fate Choice of Adult Neural Stem and Progenitor Cells

Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease

Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

Analysis of Predictive Risk Factors in Aquaporin-4-IgG Positive Highly Active Neuromyelitis Optica Spectrum Disorders